Author

Stéphanie Fitte-Duval

Inserm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Assay:spatial transcriptomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Christine SedlikiD· 2 shared Eliane PiaggioiD· 2 shared Federico MarzialiiD· 2 shared Franck BourdeautiD· 2 shared Jérémie D. GoldsteiniD· 2 shared Jimena ToselloiD· 2 shared Jordan Denizeau· 2 shared Joshua J. WaterfalliD· 2 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Christine SedlikORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Myeloid reprogramming by poly(I:C) recruits progenitor-exhausted CD8+ T cells and sensitizes rhabdoid tumors to PD-1 blockade

Valeria Sandoval Manríquez, Sofia Cavada-Silva, Kévin Beccaria, Leticia Laura Niborski, Amaury Leruste, Wilfrid Richer, Mathias Vandenbogaert, Zhi‐Yan Han, Christine Sedlik, Jordan Denizeau, Jérémy Mesple, Zoé Fusilier, Laëtitia Lesage, Jérémie D. Goldstein, Yohan Gerber-Ferder, , Eliane Piaggio

This study shows that poly(I:C) reprograms myeloid cells in rhabdoid tumors, enhancing CD8+ T cell infiltration and improving response to PD-1 blockade.

bioRxiv · Dec 29, 2025 · PreprintImmunology

Dual PD-L1/TIGIT blockade induces PNAd+ HEV-like vessels and CD62L+ lymphocyte recruitment, driving rhabdoid tumor rejection

Stéphanie Fitte-Duval, S Silva, Rafael Mena‐Osuna, Owen Hoare, Leticia Laura Niborski, Jordan Denizeau, Laëtitia Lesage, Wilfrid Richer, Christine Sedlik, Kévin Beccaria, Maëva Veyssière, Rachida Bouarich-Bourimi, Jérémie D. Goldstein, Federico Marziali, Jimena Tosello, , Eliane Piaggio

This study shows that combining PD-L1 and TIGIT blockade in a mouse model of rhabdoid tumors leads to tumor regression by promoting immune cell recruitment and vascular changes.

bioRxiv · Dec 17, 2025 · PreprintImmunology